Sleep Statistics and Prevalence Data in the United States

Authority Network America›Life Services Authority›National Health›National Sleep Authority

Sleep Statistics and Prevalence Data in the United States

Sleep disorders and chronic sleep insufficiency affect tens of millions of adults across the United States, creating a measurable burden on public health, workplace safety, and healthcare systems. This page compiles prevalence estimates, demographic breakdowns, and disorder-specific data drawn from named federal surveillance programs and peer-reviewed epidemiological sources. Understanding the scope of sleep problems at a population level is essential context for clinical decision-making, public health planning, and the regulatory context for sleep policy that governs occupational and transportation safety standards.

Definition and scope

Sleep statistics in a public health context refer to population-level estimates of sleep duration, sleep quality, and the prevalence of diagnosable sleep disorders. The primary federal surveillance instrument is the Behavioral Risk Factor Surveillance System (BRFSS), administered by the Centers for Disease Control and Prevention (CDC), which has tracked self-reported short sleep duration (defined as fewer than 7 hours per night for adults) since 2013. The CDC's Division of Population Health categorizes short sleep duration as a public health epidemic based on BRFSS findings showing that approximately 1 in 3 adults in the United States does not get sufficient sleep (CDC, Sleep and Sleep Disorders).

Additional national data come from the National Health Interview Survey (NHIS), the National Sleep Foundation's Sleep in America Poll, and the American Academy of Sleep Medicine (AASM), which publishes clinical practice guidelines and position statements that inform prevalence thresholds. The scope of "sleep statistics" therefore encompasses both behavioral data (self-reported duration and quality) and clinical data (diagnosed disorder rates). A comprehensive overview of the full topic is available through the National Sleep Authority homepage.

How it works

Federal sleep surveillance operates through three primary mechanisms:

Self-report surveys — BRFSS and NHIS collect data via telephone and in-person interviews, asking respondents to estimate their average nightly sleep duration. The BRFSS question added in 2013 reads: "On average, how many hours of sleep do you get in a 24-hour period?" Responses below 7 hours are classified as short sleep duration per AASM/Sleep Research Society joint consensus recommendations (AASM/SRS Consensus Statement, Journal of Clinical Sleep Medicine, 2015).
Clinical and insurance claims data — Disorder-specific prevalence estimates for conditions such as obstructive sleep apnea and insomnia are derived from insurance claims databases, polysomnography lab records, and specialty registry data. These figures typically undercount true prevalence because a substantial share of cases remain undiagnosed.
Objective measurement studies — Research cohorts using actigraphy and polysomnography provide objectively measured sleep data. The Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study, funded by the National Heart, Lung, and Blood Institute (NHLBI), enrolled 2,237 participants to capture objective sleep metrics across demographic groups.

Because surveillance methods differ substantially, estimates across sources are not directly comparable. Self-reported duration consistently runs higher than actigraphy-measured duration by approximately 30 to 60 minutes per night, a discrepancy documented in NHLBI-funded cohort studies.

Common scenarios

Short sleep duration prevalence by population segment

The CDC BRFSS data consistently show that short sleep duration (fewer than 7 hours) varies significantly by geography, race/ethnicity, and occupation:

Nationally, approximately 35.2% of U.S. adults report sleeping fewer than 7 hours (CDC BRFSS Sleep Data).
Non-Hispanic Black adults report short sleep at a rate of approximately 45.8%, compared to approximately 33.4% among non-Hispanic White adults, according to CDC BRFSS analyses.
Geographic clustering is pronounced: states in the Appalachian region and southeastern United States show the highest prevalence of short sleep, with Mississippi and West Virginia among states consistently exceeding 40% prevalence.

Disorder-specific prevalence

Obstructive sleep apnea (OSA): The AASM estimates that OSA affects approximately 26% of adults aged 30–70 in the United States, with 80–90% of moderate-to-severe cases undiagnosed (AASM, Journal of Clinical Sleep Medicine, 2014). The economic consequences of undiagnosed OSA are addressed in detail on the economic impact of sleep loss page.
Chronic insomnia: The AASM defines chronic insomnia as sleep difficulty occurring at least 3 nights per week for at least 3 months. Prevalence estimates range from 10% to 15% of U.S. adults meeting full diagnostic criteria, with up to 30% reporting at least occasional insomnia symptoms (AASM Clinical Practice Guidelines).
Restless legs syndrome (RLS): The National Institute of Neurological Disorders and Stroke (NINDS) reports that RLS affects approximately 7–10% of the U.S. population.
Narcolepsy: Prevalence is estimated at approximately 1 in 2,000 Americans, based on NINDS epidemiological data, making narcolepsy one of the less common but more disabling sleep disorders.

Age and developmental variation

Prevalence profiles shift substantially across the lifespan. The CDC's Youth Risk Behavior Survey (YRBS) found that approximately 72% of high school students reported sleeping fewer than 8 hours on school nights (CDC YRBS), well below the 8–10 hours recommended by the AASM for adolescents. Sleep insufficiency in children and adolescents is tracked separately from adult surveillance.

Decision boundaries

Interpreting sleep statistics requires distinguishing between four classification boundaries that affect how data should be applied:

Normative vs. clinical thresholds — A population-level finding (e.g., 35% of adults sleep fewer than 7 hours) does not mean 35% have a clinical disorder. Short sleep duration is a behavioral risk factor, not a diagnosis. Disorder diagnoses require clinical criteria defined in the International Classification of Sleep Disorders, Third Edition (ICSD-3), published by the AASM.
Self-reported vs. objective measurement — Self-report data from BRFSS and NHIS capture perceived sleep; actigraphy and polysomnography data capture physiological sleep. Policy decisions and clinical thresholds are best informed by objective measurement where feasible.
Prevalence vs. incidence — Most published sleep statistics describe prevalence (proportion of a population affected at a given point or period). Incidence data (new-onset cases per year) are scarcer and typically derived from longitudinal cohort studies such as the Sleep Heart Health Study, which is archived through the National Sleep Research Resource (NSRR), funded by NHLBI.
Diagnosed vs. undiagnosed burden — For OSA specifically, the gap between true prevalence and diagnosed prevalence is large enough that surveillance data substantially underestimate actual burden. The AASM's estimate that 80–90% of moderate-to-severe OSA cases remain undiagnosed (AASM, JCSM, 2014) means clinical claims data alone cannot serve as reliable prevalence measures.

These boundaries are particularly important when sleep statistics are used in regulatory or occupational contexts, where misclassification of risk can have safety implications. Federal transportation regulations administered by the Federal Motor Carrier Safety Administration (FMCSA) and the Federal Aviation Administration (FAA) have both cited sleep disorder prevalence data as evidence supporting hours-of-service and medical fitness standards.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)

Sleep Statistics and Prevalence Data in the United States